AAAAAA

   
Results: 1-25 | 26-43
Results: 1-25/43
BCL-X AND THE APOPTOTIC MACHINERY OF LYMPHOMA-CELLS
Authors: XERRI L HASSOUN J DEVILARD E BIRNBAUM D BIRG F
Citation: L. Xerri et al., BCL-X AND THE APOPTOTIC MACHINERY OF LYMPHOMA-CELLS, Leukemia & lymphoma, 28(5-6), 1998, pp. 451-458
ANALYSIS OF BAX EXPRESSION IN HUMAN TISSUES USING THE ANTI-BAX, 4F11 MONOCLONAL-ANTIBODY ON PARAFFIN SECTIONS
Authors: PENAULTLLORCA F BOUABDALLAH R DEVILARD E CHARTONBAIN MC HASSOUN J BIRG F XERRI L
Citation: F. Penaultllorca et al., ANALYSIS OF BAX EXPRESSION IN HUMAN TISSUES USING THE ANTI-BAX, 4F11 MONOCLONAL-ANTIBODY ON PARAFFIN SECTIONS, Pathology research and practice, 194(7), 1998, pp. 457-464
MALIGNANT MULLERIAN MIXED TUMOR OF THE UTERINE CERVIX WITH ADENOID CYSTIC COMPONENT
Authors: MATHOULINPORTIER MP PENAULTLLORCA F LABITBOUVIER C CHARAFE E MARTIN F HASSOUN J JACQUEMIER J
Citation: Mp. Mathoulinportier et al., MALIGNANT MULLERIAN MIXED TUMOR OF THE UTERINE CERVIX WITH ADENOID CYSTIC COMPONENT, International journal of gynecological pathology, 17(1), 1998, pp. 91-92
FRENCH GUIDELINES FOR MASS-SCREENING PAP SMEARS INTERNAL QUALITY-CONTROL
Authors: COCHANDPRIOLLET B ANGER E BARON V CARTIER I DORNE H DUBOISGORDEFF A HASSOUN J JOUANNELLE A LABBE S LOCQUET D MARSAN C MARTIN E MICHIELSMARZAIS D MOLINIE V MOTTOT C MUELLER B VACHERLAVENU MC VINCENT S VUONG PN
Citation: B. Cochandpriollet et al., FRENCH GUIDELINES FOR MASS-SCREENING PAP SMEARS INTERNAL QUALITY-CONTROL, Annales de pathologie, 18(3), 1998, pp. 221-226
GUIDELINES FOR GOOD PRACTICE IN PATHOLOGY AND CYTOPATHOLOGY - DOCUMENT PREPARED BY THE F-QUALITY-ASSURANCE-IN-PATHOLOGY-AND-CYTOPATHOLOGY -COMMISSION NO-4 - ORGANIZATION AND FUNCTION OF THE ACP STRUCTURES
Authors: SAINTANDRE JP DONZEL JP ANGER E CHATELET F COCHANDPRIOLLET B DEGRAEVE P GERARD F HASSOUN J HENIN D MARSAN C MARTIN E MARTIN MMJ MENCHON C MULLER B PARACHE M REY C SEVESTRE H VOIGT JJ NGOC PV ZERAT L
Citation: Jp. Saintandre et al., GUIDELINES FOR GOOD PRACTICE IN PATHOLOGY AND CYTOPATHOLOGY - DOCUMENT PREPARED BY THE F-QUALITY-ASSURANCE-IN-PATHOLOGY-AND-CYTOPATHOLOGY -COMMISSION NO-4 - ORGANIZATION AND FUNCTION OF THE ACP STRUCTURES, Annales de pathologie, 18(3), 1998, pp. 227-236
SENSITIVITY TO FAS-MEDIATED APOPTOSIS IS NULL OR WEAK IN B-CELL NON-HODGKINS-LYMPHOMAS AND IS MODERATELY INCREASED BY CD40 LIGATION
Authors: XERRI L BOUABDALLAH R DEVILARD E HASSOUN J STOPPA AM BIRG F
Citation: L. Xerri et al., SENSITIVITY TO FAS-MEDIATED APOPTOSIS IS NULL OR WEAK IN B-CELL NON-HODGKINS-LYMPHOMAS AND IS MODERATELY INCREASED BY CD40 LIGATION, British Journal of Cancer, 78(2), 1998, pp. 225-232
FAS LIGAND IS NOT ONLY EXPRESSED IN IMMUNE PRIVILEGED HUMAN ORGANS BUT IS ALSO COEXPRESSED WITH FAS IN VARIOUS EPITHELIAL TISSUES
Authors: XERRI L DEVILARD E HASSOUN J MAWAS C BIRG F
Citation: L. Xerri et al., FAS LIGAND IS NOT ONLY EXPRESSED IN IMMUNE PRIVILEGED HUMAN ORGANS BUT IS ALSO COEXPRESSED WITH FAS IN VARIOUS EPITHELIAL TISSUES, Journal of clinical pathology-Molecular pathology, 50(2), 1997, pp. 87-91
MALIGNANT AND REACTIVE CELLS FROM HUMAN LYMPHOMAS FREQUENTLY EXPRESS FAS LIGAND BUT DISPLAY A DIFFERENT SENSITIVITY TO FAS-MEDIATED APOPTOSIS
Authors: XERRI L DEVILARD E HASSOUN J HADDAD P BIRG F
Citation: L. Xerri et al., MALIGNANT AND REACTIVE CELLS FROM HUMAN LYMPHOMAS FREQUENTLY EXPRESS FAS LIGAND BUT DISPLAY A DIFFERENT SENSITIVITY TO FAS-MEDIATED APOPTOSIS, Leukemia, 11(11), 1997, pp. 1868-1877
AORTIC SARCOMAS WITH PERIPHERAL EMBOLI
Authors: DANIEL L FIGARELLABRANGER D TOURNIGAND P HASSOUN J PELLISSIER JF
Citation: L. Daniel et al., AORTIC SARCOMAS WITH PERIPHERAL EMBOLI, La Revue de medecine interne, 18(10), 1997, pp. 799-805
CLEAR-CELL SARCOMA OF THE KIDNEY - A RELA PSE AFTER 10 YEARS WITHOUT RECURRENCE
Authors: CHARAFE E PENAULTLLORCA F MATHOULINPORTIER MP BLADOU F DELPERO JR PRIMEGUITTON C VIEILLEFOND A XERRI L HASSOUN J
Citation: E. Charafe et al., CLEAR-CELL SARCOMA OF THE KIDNEY - A RELA PSE AFTER 10 YEARS WITHOUT RECURRENCE, Annales de pathologie, 17(6), 1997, pp. 400-402
A EXCEPTIONAL VARIETY OF MEDULLOBLASTOMA - MELANOTIC MEDULLOBLASTOMA
Authors: BAYLAC F MARTINOLI A MARIE B BRACARD S MARCHAL JC BEY P SOMMELET D HASSOUN J PLENAT F
Citation: F. Baylac et al., A EXCEPTIONAL VARIETY OF MEDULLOBLASTOMA - MELANOTIC MEDULLOBLASTOMA, Annales de pathologie, 17(6), 1997, pp. 403-405
JUXTACORTICAL CHONDROSARCOMA - A DIFFEREN T ENTITY FROM PERIOSTEAL OSTEOSARCOMA
Authors: MATHOULINPORTIER MP PORTIER F PENAULTLLORCA F POITOUT D CHAMLIAN A HASSOUN J GARBE L
Citation: Mp. Mathoulinportier et al., JUXTACORTICAL CHONDROSARCOMA - A DIFFEREN T ENTITY FROM PERIOSTEAL OSTEOSARCOMA, Annales de pathologie, 17(5), 1997, pp. 369-370
EXTERNAL QUALITY ASSESSMENT OF IMMUNOHIST OCHEMISTRY - RESULTS OF A PRELIMINARY MULTICENTRIC STUDY
Authors: AUDOUIN J BALATON AJ BELLOCQ JP BROUSSE N DELSOL G GAULIER A DUPUY CHV GOSSELIN B HASSOUN J HEM B MONGES G SAINTANDRE JP WECHSLER J
Citation: J. Audouin et al., EXTERNAL QUALITY ASSESSMENT OF IMMUNOHIST OCHEMISTRY - RESULTS OF A PRELIMINARY MULTICENTRIC STUDY, Annales de pathologie, 17(2), 1997, pp. 129-133
CYSTEINE PROTEASE CPP32, BUT NOT ICH1-L, IS EXPRESSED IN GERMINAL CENTER B-CELLS AND THEIR NEOPLASTIC COUNTERPARTS
Authors: XERRI L DEVILARD E AYELLO C BROUSSET P REED JC EMILE JF HASSOUN J PARMENTIER S BIRG F
Citation: L. Xerri et al., CYSTEINE PROTEASE CPP32, BUT NOT ICH1-L, IS EXPRESSED IN GERMINAL CENTER B-CELLS AND THEIR NEOPLASTIC COUNTERPARTS, Human pathology, 28(8), 1997, pp. 912-921
TUMOR ANGIOGENESIS IS NOT A PREDICTIVE MARKER OF RESPONSIVENESS TO CONVENTIONAL ADJUVANT CHEMOTHERAPY
Authors: PENAULTLLORCA F SUN ZZ VIENS P GENEIX J HASSOUN J BIRNBAUM D JACQUEMIER J
Citation: F. Penaultllorca et al., TUMOR ANGIOGENESIS IS NOT A PREDICTIVE MARKER OF RESPONSIVENESS TO CONVENTIONAL ADJUVANT CHEMOTHERAPY, Laboratory investigation, 76(1), 1997, pp. 116-116
IN-VIVO EXPRESSION OF THE CTLA4 INHIBITORY RECEPTOR IN MALIGNANT AND REACTIVE CELLS FROM HUMAN LYMPHOMAS
Authors: XERRI L DEVILARD E HASSOUN J OLIVE D BIRG F
Citation: L. Xerri et al., IN-VIVO EXPRESSION OF THE CTLA4 INHIBITORY RECEPTOR IN MALIGNANT AND REACTIVE CELLS FROM HUMAN LYMPHOMAS, Journal of pathology, 183(2), 1997, pp. 182-187
IN-VIVO EXPRESSION OF THE CTLA4 INHIBITORY RECEPTOR IN MALIGNANT AND REACTIVE CELLS FROM HUMAN LYMPHOMAS
Authors: XERRI L DEVILARD E HASSOUN J BOUABDALLAH R STOPPA AM OLIVE D BIRG F
Citation: L. Xerri et al., IN-VIVO EXPRESSION OF THE CTLA4 INHIBITORY RECEPTOR IN MALIGNANT AND REACTIVE CELLS FROM HUMAN LYMPHOMAS, Blood, 90(10), 1997, pp. 3966-3966
SENSITIVITY TO FAS-MEDIATED APOPTOSIS IS NULL OR WEAK IN NEOPLASTIC-CELLS FROM MOST SUBTYPES OF B-CELL NON-HODGKINS-LYMPHOMAS AND IS ONLY MODERATELY INCREASED BY CD40 LIGATION
Authors: XERRI L DEVILARD E HASSOUN J BOUABDALLAH R BIRG F
Citation: L. Xerri et al., SENSITIVITY TO FAS-MEDIATED APOPTOSIS IS NULL OR WEAK IN NEOPLASTIC-CELLS FROM MOST SUBTYPES OF B-CELL NON-HODGKINS-LYMPHOMAS AND IS ONLY MODERATELY INCREASED BY CD40 LIGATION, Blood, 90(10), 1997, pp. 323-323
EXPRESSION OF FGF1 AND FGFR1 IN HUMAN-MELANOMA TISSUES
Authors: XERRI L BATTYANI Z GROB JJ PARC P HASSOUN J BONERANDI JJ BIRNBAUM D
Citation: L. Xerri et al., EXPRESSION OF FGF1 AND FGFR1 IN HUMAN-MELANOMA TISSUES, Melanoma research, 6(3), 1996, pp. 223-230
PANCREATIC AND DUODENAL SOMATOSTATINOMAS - 2 ANATOMOCLINIC ENTITIES
Authors: MATHOULINPORTIER MP PAYAN MJ MONGES G PENAULTLLORCA F BARTHET M SASTRE B GIOVANNINI M DELPERO JR HASSOUN J
Citation: Mp. Mathoulinportier et al., PANCREATIC AND DUODENAL SOMATOSTATINOMAS - 2 ANATOMOCLINIC ENTITIES, Annales de pathologie, 16(4), 1996, pp. 299-302
IS AN HISTOLOGICAL EXAMINATION ALWAYS REQ UESTED - RESPONSE
Authors: HASSOUN J
Citation: J. Hassoun, IS AN HISTOLOGICAL EXAMINATION ALWAYS REQ UESTED - RESPONSE, Annales de dermatologie et de venereologie, 123(5), 1996, pp. 370-370
MOLECULAR ANALYSIS OF THE NPM-ALK REARRANGEMENT IN HODGKINS-DISEASE
Authors: XERRI L PARC P HASSOUN J BIRNBAUM D
Citation: L. Xerri et al., MOLECULAR ANALYSIS OF THE NPM-ALK REARRANGEMENT IN HODGKINS-DISEASE, Journal of pathology, 178(2), 1996, pp. 128-132
PREDOMINANT EXPRESSION OF THE LONG ISOFORM OF BCL-X (BCL-XL) IN HUMANLYMPHOMAS
Authors: XERRI L PARC P BROUSSET P SCHLAIFER D HASSOUN J REED JC KRAJEWSKI S BIRNBAUM D
Citation: L. Xerri et al., PREDOMINANT EXPRESSION OF THE LONG ISOFORM OF BCL-X (BCL-XL) IN HUMANLYMPHOMAS, British Journal of Haematology, 92(4), 1996, pp. 900-906
FREQUENT EXPRESSION OF FAS APO-1 IN HODGKINS-DISEASE AND ANAPLASTIC LARGE-CELL LYMPHOMAS/
Authors: XERRI L CARBUCCIA N PARC P HASSOUN J BIRG F
Citation: L. Xerri et al., FREQUENT EXPRESSION OF FAS APO-1 IN HODGKINS-DISEASE AND ANAPLASTIC LARGE-CELL LYMPHOMAS/, Histopathology, 27(3), 1995, pp. 235-241
PCR-MISMATCH ANALYSIS OF P53 GENE MUTATION IN HODGKINS-DISEASE
Authors: XERRI L PARC P BOUABDALLAH R CAMERLO J HASSOUN J
Citation: L. Xerri et al., PCR-MISMATCH ANALYSIS OF P53 GENE MUTATION IN HODGKINS-DISEASE, Journal of pathology, 175(2), 1995, pp. 189-194
Risultati: 1-25 | 26-43